ARCHIVES
VOL. 2, ISSUE 4 (2020)
A study of immuno-histochemical markers estrogen receptor and progesterone receptor in ovarian neoplasms
Authors
Anjana choudhary, Geeta Pachori, Saroj pachori, Nishi Dixit
Abstract
Introduction: Among genital malignancies, Ovarian Cancer has the most increased mortality rate. ER and PR expression levels depend on tumour histologic grade and stage of disease and are variable between tumours of the same grade. Aims: To study the clinicopathological parameters in ovarian tumours with reference to age, histologic type and grade and their correlation with ER and PR status. Methodology: The prospective study of 2 ½ years was conducted on 100 resected ovarian tumour specimens from June 2017 to December 2019 received in the Department of Pathology, JLN Medical College, Ajmer. Sections were stained and examined for presence of ovarian tumour, Histological type, Grade and for ER and PR status, immunohistochemistry was done. Results: Out of 100 cases, 72 cases were benign, 03 cases were borderline and 25 cases were malignant. 60% were of surface epithelial neoplasm, followed by germ cell tumors. Serous tumors were most common among all epithelial tumors (61%). Malignant cases showed maximum positivity with ER and PR as 61.76% and 68% respectively. ER and PR positivity in serous epithelial tumors was 76.47% and 84% and in mucinous tumors was 20.59% and 12% respectively. ER and PR positivity in endometrioid tumor was 2.94% and 4% respectively. Majority of positive ER and PR receptors was observed in Age groups of >40 years as 64.71% and 64% respectively. ER and PR positivity seen in higher grade and stage tumors as 76.19% and 76.47% in grade 3 and stage 3 tumors respectively. Conclusion: The higher expression of ER and PR is associated with progression of invasive cancer, higher grade and stage of ovarian tumors, higher age group, and mulitparity.
Download
Pages:34-37
How to cite this article:
Anjana choudhary, Geeta Pachori, Saroj pachori, Nishi Dixit "A study of immuno-histochemical markers estrogen receptor and progesterone receptor in ovarian neoplasms". International Journal of Medical Science and Clinical Research, Vol 2, Issue 4, 2020, Pages 34-37
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.

